Professor Tom Rapoport from the Department of Cell Biology, Harvard Medical School will give the inaugural Milstein Lecture on Thursday April 7th 2011 at 4.15 pm in the LMB’s Max Perutz Lecture Theatre. The lecture is open to anyone in the local area who is interested in attending. Tom graduated with honours and then earned […]
2011 César Milstein Lecture to be given by Tom Rapoport.
Hijacking protein quality control to regulate cellular communication.
When the first multicellular organisms evolved, their cells needed to communicate with each other to control their growth and development. Matthew Freeman’s group from the LMB’s Cell Biology Division, led by the postdoc Markus Zettl, has shown that one way they did this was to exploit much more ancient protein quality control machinery Matthew’s group […]
Peter Lawrence: lifetime achievement award.
Peter Lawrence, an Emeritus member of the LMB, has been honoured with the 2011 Society for Developmental Biology (SDB) Lifetime Achievement Award. The SDB gives its Lifetime Achievement Award annually to a senior developmental biologist in recognition of their outstanding and lasting contributions in the field. The award is given for the individual’s excellence in […]
LMB at the Cambridge Science Festival: 19th March.
On Saturday 19th March 2011, as part of the annual Cambridge Science Festival, LMB scientists are involved in events across Cambridge aimed at promoting science to the general public. Crystal Clear Exhibit Crystal Clear is an exhibit run by the LMB’s Samantha Wynne and Harry Powell, showing various types and sizes of crystalline materials, from large […]
Heptares Therapeutics helps push GPCR drug discovery forward
“G-protein-coupled receptors are hot drug targets, and plenty of companies want to know what they look like to get an edge on making new drugs. Despite recent advances, getting X-ray crystal structures for GPCRs is still far from easy. Heptares Therapeutics, joins a trio of firms in licensing their structure-determining technology and partnering with large […]
Human antibody approved for treatment of lupus
Systemic lupus erythematosus is a chronic, life-threatening inflammatory autoimmune disease that can cause debilitating fatigue, painful and swollen joints, fever, skin rash, and kidney problems. The disease can also lead to arthritis, kidney failure, heart and lung inflammation, central nervous system abnormalities, inflammation of the blood vessels, and blood disorders. Approximately five million people worldwide […]